pA2 is a quantitative measure of antagonist affinity for a receptor, expressed as the negative logarithm of the molar concentration of antagonist required to double the agonist dose needed to achieve the same biological effect (Neubig et al., 2003).
What is pA2 used for?
pA2 is primarily used in Schild analysis to characterize competitive antagonists, distinguishing their type and quantifying potency (Arunlakshana & Schild, 1959).
Here’s the thing: by measuring how much extra agonist is needed when an antagonist is present to restore a given response, researchers can determine if the antagonist is surmountable. Then they calculate its affinity—the pA2 value. This method is foundational in drug development for receptor targets, letting scientists see how tightly a drug binds and how effective it might be therapeutically.
What is the pA2 of a drug?
The pA2 of a drug is the negative logarithm of the molar concentration of antagonist that doubles the effective dose of an agonist required to produce the same pharmacological response (Schild, 1949).
Say a drug has a pA2 of 7. That means the antagonist concentration is 10⁻⁷ M. This value tells you how well the antagonist competes with the agonist for receptor binding. Drugs with higher pA2 values pack more punch as antagonists because they need lower concentrations to shift the agonist dose-response curve.
What does a high pA2 value mean?
A high pA2 value indicates a high affinity of the antagonist for its receptor, meaning it binds more tightly and requires a lower concentration to inhibit agonist activity (Neubig et al., 2003).
Think of it this way: a pA2 of 9 is stronger than a pA2 of 6. You can see this on a Schild plot, where a slope near unity and a high pA2 confirm competitive antagonism with strong receptor binding. Clinically, such antagonists may work well even at low doses, which can mean fewer side effects.
How do you calculate kd from pA2?
You calculate the dissociation constant (KD) from pA2 using the equation pA2 = –log(KD), so KD = 10^(–pA2) (Schild, 1949).
Imagine a pA2 of 8. That corresponds to a KD of 10⁻⁸ M. This calculation assumes competitive antagonism and equilibrium conditions, and it lets pharmacologists turn functional assay data (pA2) into a thermodynamic binding constant (KD). That’s crucial for comparing drug affinities across studies.
What does pD2 value indicate?
pD2 indicates the affinity of a non-competitive or irreversible antagonist, defined as the negative logarithm of the antagonist concentration that reduces the maximum agonist effect by 50% (Kenakin, 2017).
It shows how effectively an antagonist suppresses receptor function, even when agonist levels are high. Unlike pA2, pD2 applies to antagonists that can’t be overcome by adding more agonist. A higher pD2 means the antagonist is more potent at reducing the maximal response.
What is IC value?
IC50 is the half-maximal inhibitory concentration, representing the molar concentration of a substance needed to inhibit a biological process by 50% (Cheng & Prusoff, 1973).
IC50 is everywhere—enzyme inhibition, receptor blockade, microbial assays. It helps compare inhibitors, but it changes with experimental conditions, so researchers often convert it to Ki (inhibition constant) using the Cheng-Prusoff equation for a fairer comparison.
How is pD2 calculated?
pD2 is calculated as pD2 = –log(EC50) or –log of the antagonist concentration that reduces the maximal agonist response by half (Kenakin, 2017).
For example, if 10⁻⁶ M of antagonist cuts the maximum effect in half, the pD2 is 6. This value comes from dose-response curves with irreversible or non-competitive antagonists. It’s a key metric in pharmacodynamics for drugs that tweak receptor efficacy.
What is pA in pharmacology?
In pharmacology, pA refers to the negative logarithm of the molar concentration of an antagonist that produces a defined shift in the agonist dose-response curve (Schild, 1949).
pA values are general descriptors used in Schild analysis, where pA2 is a specific case (a 2-fold shift). The method compares agonist responses before and after adding antagonist to classify drug behavior—agonist, antagonist, or mixed—and to assess receptor interaction.
What does a Schild plot tell you?
A Schild plot determines the equilibrium constant (pA2) for a competitive antagonist and confirms the nature of antagonism by analyzing the dose ratio across antagonist concentrations (Arunlakshana & Schild, 1959).
The plot’s slope and linearity reveal whether the antagonism is competitive. A slope of 1 and a linear regression validate the model. This analysis is a cornerstone of receptor pharmacology and drug screening, letting researchers precisely quantify antagonist affinity and mechanism.
How do you tell if a drug is an agonist or antagonist?
A drug is an agonist if it binds to a receptor and produces a response similar to the endogenous ligand, while an antagonist binds without activating the receptor and blocks or reduces the response (Rang et al., 2016).
Agonists mimic natural signaling, ramping up cellular activity. Antagonists block agonists from binding, dampening function. Partial agonists give submaximal responses. Distinguishing them often involves dose-response experiments and Schild analysis when receptor competition is in play.
How do you interpret EC50?
EC50 is the concentration of a drug at which 50% of its maximal effect is observed on a graded dose-response curve, expressed in molar units (M) (Motulsky & Christopoulos, 2004).
Lower EC50 values signal higher potency—less drug needed for half-maximal effect. Researchers use EC50 to compare drugs acting on the same target. For safety, they often weigh EC50 against toxic concentrations to calculate the therapeutic index.
What does a negative pA2 mean?
A negative pA2 value indicates that the antagonist concentration required to double the agonist dose is greater than 1 M, suggesting very low affinity or poor receptor binding (Neubig et al., 2003).
Since pA2 is –log([B]), a negative value means [B] > 1, which isn’t realistic for most drugs. It might point to experimental error, non-competitive antagonism, or assay issues. Proper interpretation means confirming competitive antagonism and checking for methodological problems.
How do you calculate kd from IC50?
You calculate KD from IC50 using the Cheng-Prusoff equation: IC50 = Ki × (1 + [L]/KD), rearranged to solve for KD when Ki and ligand concentration are known (Cheng & Prusoff, 1973).
KD reflects receptor binding affinity in a clean system. IC50, however, depends on experimental conditions, including ligand concentration. To get an accurate KD from IC50, you need to know the assay’s ligand concentration and the inhibitor’s Ki value—often found in separate binding studies.
Can IC50 be lower than KD?
Yes, IC50 can be lower than KD in conditions of slow binding kinetics, high ligand depletion, or covalent modification of the receptor (Copeland et al., 2006).
This happens when IC50 approaches (1/2)[E] or when the inhibitor forms a tight complex over time. In these cases, IC50 underestimates true affinity. Researchers should rely on Ki or KD from direct binding assays when IC50 strays from expected values.
How do you calculate KD in pharmacology?
To calculate KD, incubate a fixed amount of receptor-containing membranes with increasing concentrations of radiolabeled ligand until saturation; KD is the ligand concentration at which 50% of receptors are occupied (Motulsky & Christopoulos, 2004).
Bmax (maximum binding) comes from the saturation curve, and KD is the ligand concentration at Bmax/2. This radioligand binding assay directly measures receptor affinity and is the gold standard in pharmacology for quantifying drug-receptor interactions.
